PQA is a non-profit organization with 175 diverse members across healthcare. Our members include community and specialty pharmacy organizations, pharmacists and other healthcare providers, pharmacies, health plans, pharmacy benefit managers, life sciences, technology vendors, government agencies, health information technology partners, researchers, accrediting organizations and academia.
Welcome to Five For Friday!
This guest blog is one in a series by sponsors of the 2025 PQA Annual Meeting on bridging payers and pharmacies to drive better care and lower costs. PQA does not endorse, recommend or favor any product, service or organization that is a sponsor.
The PQA Board of Directors represents a diverse group of thought leaders and experts in health care, who understand how medication optimization improves patient outcomes and supports a value-based care system. Their expertise helps PQA advance the safe and appropriate use of medicines. This blog is one in a series profiling PQA's Board members.
Welcome to Five For Friday!
The PQA Postdoctoral Executive Fellowship helps produce the next generation of leaders in health care quality through a full-time, 12-month program. Executive Fellows collaborate with PQA staff, members and other stakeholders on a variety of initiatives to improve medication use quality. During the fellowship, individuals will expand their skills and experience in project management, quality measure design and implementation, non-profit administration and association management, and health care quality research.
The 2025 PQA Annual Meeting poster session will showcase 19 quality improvement and research projects. This session provides authors a venue to exhibit their work and enables attendees to engage in insightful discussions about health care quality.
With the volatility and uncertainty of today’s market, we’re all watching budgets and expenditures closely.
The evolution of PQA’s continued involvement in medication therapy management (MTM) spans over a decade. Milestones include endorsement of the Completion Rate for Comprehensive Medication Review performance measure in 2011 and development of the foundational Medication Therapy Problem Categories Framework in 2017.
The evolution of PQA’s continued involvement in medication therapy management (MTM) spans over a decade. The first blog in a series to detail PQA’s MTM initiative outlines PQA’s six objectives to advance MTM quality. This blog will address the first objective to promote a standard of care for MTM through education on using the PQA Medication Therapy Problem (MTP) Categories FrameworkTM in the Pharmacist’s Patient Care Process.
Welcome to Five For Friday!
PQA is launching a Health Plan Measure Concept Advisory Group (MCAG) to review and provide input on measure concepts for development in 2026 and beyond. The group will provide guidance to prioritize health plan measure concepts, evaluating key criteria such as:
Welcome to the 100th edition of Five For Friday!
In 2023, PQA launched a multiphase national medication therapy management (MTM) initiative to address stakeholder needs and advance MTM quality measurement. PQA has identified six objectives that can advance MTM quality and measurement, and the MTM Advisory Group is serving as a forum providing expert feedback on how to approach these.
PQA is now accepting self-nominations for the Diversity in Quality Scholarship. The program provides scholarships for health care professional students to attend the 2025 PQA Annual Meeting, May 19-21, in Tampa, Fla., and participate in the pre-meeting Medication Use Quality Live workshop on May 19.
PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a person’s ability to access and use medications.
The Medicare Part D medication therapy management (MTM) program aims to optimize therapeutic outcomes and reduce the risk of adverse events and associated costs by identifying and addressing medication therapy problems. There are specific eligibility criteria for Medicare beneficiaries to take advantage of these services. However, a significant portion of those eligible do not choose to participate in the program.
Join us as we head to the Sunshine State for the 2025 PQA Annual Meeting, May 19-21! Meeting registration and hotel reservations are now open—don’t miss your chance to participate! Make your plans to join us and other quality professionals in Tampa at the primer event for quality medication use.
PQA and research partners at the University of Arizona, the University of Health Sciences and Pharmacy in St. Louis, and Merck & Co. recently conducted patient interviews to explore patients’ perceptions of their experience with comprehensive medication reviews (CMR).
PQA has published a new report that summarizes the conversations from PQA Convenes: Quality Medication Use in Rare Disease, held on November 7, which brought together health care quality experts, rare disease leaders and individuals with lived experience to discuss what constitutes high-quality rare disease medication use.
